| |
| |
|
| Insider
Information: |
Lis William |
| Relationship: |
Director |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
300,202 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$5,372,194 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
300,202 |
|
|
| Total
Value |
$5,372,194 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Portola Pharmaceuticals Inc |
PTLA |
Chief Executive Office... |
2018-08-23 |
204,448 |
2014-05-21 |
0 |
Premium* |
|
|
Zai Lab Ltd |
ZLAB |
|
2023-06-29 |
42,233 |
2021-01-15 |
0 |
Premium* |
|
|
Amplitude Healthcare Acquisition... |
AMHCU |
Director |
2023-10-13 |
53,521 |
2022-03-21 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PTLA |
Portola Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2017-06-27 |
4 |
AS |
$54.92 |
$14,144,921 |
D/D |
(255,149) |
0 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2015-07-15 |
4 |
AS |
$50.00 |
$2,500,000 |
D/D |
(50,000) |
0 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2017-06-27 |
4 |
OE |
$7.00 |
$2,116,243 |
D/D |
255,149 |
20,000 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2015-04-30 |
4 |
AS |
$35.60 |
$1,602,058 |
D/D |
(45,000) |
0 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2017-06-28 |
4 |
AS |
$55.35 |
$783,203 |
D/D |
(14,150) |
0 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2015-07-02 |
4 |
AS |
$45.60 |
$684,045 |
D/D |
(15,000) |
0 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2015-07-01 |
4 |
AS |
$45.54 |
$683,093 |
D/D |
(15,000) |
0 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2015-06-30 |
4 |
AS |
$44.03 |
$667,148 |
D/D |
(15,000) |
0 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2018-03-02 |
4 |
D |
$32.53 |
$624,056 |
D/D |
(19,184) |
70,624 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2015-01-20 |
4 |
AS |
$27.32 |
$546,438 |
D/D |
(20,000) |
0 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2017-03-02 |
4 |
D |
$38.61 |
$527,760 |
D/D |
(13,669) |
112,839 |
0 |
- |
|
| ZLAB |
Zai Lab Ltd |
|
– • – |
2023-06-29 |
4 |
A |
$26.45 |
$499,984 |
D/D |
18,903 |
42,233 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2018-08-23 |
4 |
D |
$26.05 |
$458,141 |
D/D |
(17,587) |
204,448 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2015-07-15 |
4 |
OE |
$8.50 |
$425,000 |
D/D |
50,000 |
50,000 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2017-08-16 |
4 |
D |
$54.86 |
$407,884 |
D/D |
(7,435) |
0 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2014-11-20 |
4 |
AS |
$26.98 |
$404,723 |
D/D |
(15,000) |
0 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2014-11-19 |
4 |
AS |
$26.68 |
$400,260 |
D/D |
(15,000) |
0 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2015-01-16 |
4 |
AS |
$27.01 |
$364,202 |
D/D |
(13,476) |
0 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2015-04-30 |
4 |
OE |
$7.00 |
$315,000 |
D/D |
45,000 |
45,000 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2014-07-02 |
4 |
AS |
$30.74 |
$307,430 |
D/D |
(10,000) |
0 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2014-07-03 |
4 |
AS |
$30.46 |
$304,590 |
D/D |
(10,000) |
0 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2014-07-01 |
4 |
AS |
$30.03 |
$300,320 |
D/D |
(10,000) |
0 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2014-06-30 |
4 |
AS |
$29.23 |
$292,310 |
D/D |
(10,000) |
0 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2014-11-18 |
4 |
AS |
$27.32 |
$273,170 |
D/D |
(10,000) |
0 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2014-11-13 |
4 |
AS |
$26.57 |
$267,584 |
D/D |
(10,000) |
0 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
